Halozyme Therapeutics shares owned by Blueshift Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Blueshift Asset Management
from 13F filings
Historical chart of Blueshift Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by Blueshift Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $534k | 8.3k | 64.63 |
| 2025-06-30 | $573k | 11k | 52.02 |
| 2021-09-30 | $781k | 19k | 40.68 |
| 2021-06-30 | $553k | 12k | 45.42 |
| 2021-03-31 | $348k | 8.3k | 41.74 |
| 2019-12-31 | $309k | 17k | 17.73 |
More positions owned by Blueshift Asset Management
View all positions for Blueshift Asset Management